
Subject to intense pressure over the last few days, Mylan has made an attempt to avoid becoming “another Valeant” by …
Jager-van Dijk is new Arletta Pharma Solutions CEO
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

